Displaying 1 - 1 of 1
| Active Ingredient | CYTARABINE |
| Therapeutic Class | ANTINEOPLASTICS |
| Indications | Induction of remission of acute myeloblastic leukaemia. |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | Cytarabine can cause fetal toxicity when administered to pregnant women, but pot More ... |
| Breast Feeding | Discontinue breast-feeding. |